{"dataset":{"name":"OECD Health: Health expenditure and financing","slug":"dsd-sha-df-sha"},"field":"health_function","members":["Administration of health financing","Ancillary services (non-specified by function)","Basic healthcare services","Basic healthcare services and pharmaceuticals","COVID-19 related costs for medical goods","COVID-19 related costs for testing and contact tracing","COVID-19 related costs for vaccination","COVID-19 related investment costs","COVID-19 related provider support","COVID-19 related treatment costs","Collective healthcare","Curative and rehabilitative care","Curative care","Current expenditure on health plus gross fixed capital formation","Dental curative care","Early disease detection programmes","Epidemiological surveillance and risk and disease control programmes","General curative care","Governance and health system administration","Governance and health system and financing administration","Health promotion with multi-sectoral approach","Healthy condition monitoring programmes","Imaging services","Immunisation programmes","Individual healthcare services","Individual healthcare services and medical goods","Information, education and counseling programmes","Laboratory services","Long-term care (health)","Long-term care (social)","Medical goods (non-specified by function)","Other COVID-19 related healthcare costs (incl. in CHE)","Other curative care","Other healthcare services unknown","Other medical non-durable goods","Over-the-counter medicines","Patient transportation","Pharmaceuticals and other medical non-durable goods","Preparing for disaster and emergency response programmes","Prescribed medicines","Preventive care","Rehabilitative care","Specialised curative care","Therapeutic appliances and other medical durable goods","Total","Total long-term care expenditure","Total pharmaceutical expenditure (including inpatient and other ways of provision)","Traditional, Complementary and Alternative Medicines (TCAM)"]}